Clinical Trials Logo

Clinical Trial Summary

The treatment system consists of two light-weight MyMove bands and virtual-reality gear. Built-in software allows tracking of performance in real-time, with feedback to both the patient and treating personnel. MyMove is a wearable device that allows patients with loss of upper-limb function to operate computers, cellular phones, and similar devices. The technology is non-invasive and does not involve risk to the patient. MyMove+ is a Physical Medicine and Rehabilitation software intended for use in upper extremity and full-body conventional rehabilitation by: 1. Tracking motion and movement kinematics. 2. Guiding patients in the performance of physical exercises according to the treating practitioner's guidelines. MyMove+ software is not intended for use in diagnosis, treatment or decision-making, or as a stand-alone device.


Clinical Trial Description

A non-blinded controlled study of adults, ages 18-65, with unilateral, below-knee limb amputation. All subjects will be initially evaluated by a single group of licensed physical- and occupational therapists. Following a structured introductory session, subjects will be assigned to MyMove devices and VR gear for a total of 10 sessions over a period of 5 weeks (15-20 minutes per session). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04955613
Study type Interventional
Source 6Degrees LTD
Contact Miri Berger
Phone +9720522700352
Email mb@6degrees.tech
Status Recruiting
Phase N/A
Start date July 29, 2021
Completion date August 1, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT03694639 - CT-guided Ganglion Impar Block for Management of Phantom Rectal Pain Syndrome Phase 4
Recruiting NCT03415360 - Cryolesion in Treatment of Phantom Limb Pain N/A
Completed NCT01928849 - Valproic Acid for the Prevention of Post-Amputation Pain Phase 2